GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Equasens (XPAR:EQS) » Definitions » Stock Based Compensation

Equasens (XPAR:EQS) Stock Based Compensation : €0.0 Mil (TTM As of Jun. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Equasens Stock Based Compensation?

Equasens's Stock Based Compensation for the six months ended in Jun. 2023 was €0.0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2023 was €0.0 Mil.


Equasens Stock Based Compensation Historical Data

The historical data trend for Equasens's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Equasens Stock Based Compensation Chart

Equasens Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Equasens Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Equasens Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.0 Mil.


Equasens Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Equasens's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Equasens (XPAR:EQS) Business Description

Traded in Other Exchanges
Address
5 Allee de Saint-Cloud, Technopole de Nancy Brabois, Villers-les-Nancy, FRA, 54600
Equasens is engaged in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centres) and patients in both primary and secondary care sectors. With operations in France, Italy, Belgium, Luxembourg and the United Kingdom, Equasens is developing the healthcare platform and an ecosystem in France and Europe benefiting people by making available its technology services.

Equasens (XPAR:EQS) Headlines

From GuruFocus

Equus Announces First Quarter Net Asset Value

By GuruFocusNews GuruFocusNews 07-01-2022

Equus Announces Second Quarter Net Asset Value

By Marketwired 08-15-2023

Equus Shareholders Grant Authorization to Withdraw BDC Election

By Value_Insider Value_Insider 11-03-2022

Equus Announces Second Quarter Net Asset Value

By Value_Insider Value_Insider 11-14-2022

Equus Announces First Quarter Net Asset Value

By Marketwired Marketwired 05-14-2021

Equus Announces Results of Annual Shareholder Meeting

By GuruFocusNews GuruFocusNews 07-03-2022

Equus Shareholders Grant Authorization to Withdraw BDC Election

By GlobeNewswire GlobeNewswire 11-03-2022

Equus Announces First Quarter Net Asset Value

By GuruFocusNews GuruFocusNews 05-22-2022

Equus Announces Third Quarter Net Asset Value

By GuruFocusNews GuruFocusNews 11-15-2021

Equus Announces Results of Annual Shareholder Meeting

By PurpleRose PurpleRose 07-13-2022